Applying RNAi for cancer target validation

被引:0
|
作者
Keating, KE [1 ]
Murphy, F [1 ]
Hayes, I [1 ]
机构
[1] EiRx Therapeut, Cork, Ireland
来源
GENETIC ENGINEERING NEWS | 2004年 / 24卷 / 15期
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:36 / 36
页数:1
相关论文
共 50 条
  • [21] Current efforts in the analysis of RNAi and RNAi target genes
    Bengert, P
    Dandekar, T
    BRIEFINGS IN BIOINFORMATICS, 2005, 6 (01) : 72 - 85
  • [22] Target identification and validation in pancreatic cancer
    del Amo, J.
    de los Toyos, J. R.
    Garcia, C.
    Martinez-Torrecuadrada, J. L.
    Ochoa, G.
    Vazquez, L.
    Martinez, A.
    Martinez-Torrecuadrada, J. L.
    Barneo, L.
    Simon, L.
    EJC SUPPLEMENTS, 2005, 3 (02): : 54 - 54
  • [23] RNAi invigorates target ID & validation efforts - As enabling tool & potential therapeutic, RNAi opens avenues for research service providers & pharmas
    Kerr, E
    GENETIC ENGINEERING NEWS, 2004, 24 (01): : 20 - +
  • [24] Application of RNA interference (RNAi) technology for target validation in cultured human tissue explants.
    Song, Lily
    Tortorella, Micky
    Malfait, Anne-Marie
    Amer, Elizabeth
    Griggs, David W.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 256 - 256
  • [25] TAG-RNAi overcomes off-target effects in cancer models
    Champagne, Julien
    Linares, Laetitia K.
    Maurel, Benjamin
    Zampieri, Alexandre
    Moreno, Maeva
    Fuentes, Ivanna
    Dubois, Emeric
    Severac, Dany
    Decorsiere, Adrien
    Bienvenu, Frederic
    ONCOGENE, 2020, 39 (04) : 935 - 945
  • [26] Advancing cancer target discovery through vector-mediated RNAi.
    Cleary, Michele
    Klinghoffer, Richard
    Chau, Nelson
    Linsley, Peter
    CANCER RESEARCH, 2006, 66 (08)
  • [27] Engineering Multifunctional RNAi Nanomedicine To Concurrently Target Cancer Hallmarks for Combinatorial Therapy
    Liu, Yanlan
    Ji, Xiaoyuan
    Tong, Winnie W. L.
    Askhatova, Diana
    Yang, Tingyuan
    Cheng, Hongwei
    Wang, Yuzhuo
    Shi, Jinjun
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2018, 57 (06) : 1510 - 1513
  • [28] Common pitfalls in preclinical cancer target validation
    Kaelin, William G., Jr.
    NATURE REVIEWS CANCER, 2017, 17 (07) : 441 - 450
  • [29] Validation of γ-actin as a potential target in breast cancer
    Shahbazi, RI
    McCann, A
    Frawley, A
    Doran, P
    Chung, WY
    Dervan, P
    Kerin, MJ
    BRITISH JOURNAL OF SURGERY, 2004, 91 (09) : 1216 - 1216
  • [30] Validation of phosphodiesterase 10A as a cancer target
    Lee, Kevin
    Li, Nan
    Chen, Xi
    Zhu, Bing
    Yet, Larry
    da Silva, Luciana Madeira
    Russo, Suzanne
    Keeton, Adam B.
    Boyd, Michael R.
    Piazza, Gary A.
    CANCER RESEARCH, 2015, 75